Left main coronary artery (LMCA): The proximal segment

Similar documents
Catch-up Phenomenon: Insights from Pathology

Pathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005

2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57:

Drug Eluting Stent DES Pathology Update What we know, what we do not know

Assessment of Vulnerable Plaque by IVUS and VH-IVUS

OCT Findings: Lesson from Stable vs Unstable Plaques

Sites of Atherosclerosis In order of Frequency

Optical Coherence Tomography for Intracoronary Imaging

Can IVUS Define Plaque Features that Impact Patient Care?

LM stenting - Cypher

Basics of Angiographic Interpretation Analysis of Angiography

CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus

Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging

Side Branch Occlusion

Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD

Plaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Imaging Atheroma The quest for the Vulnerable Plaque

Review Article Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement

Bifurcation stenting with BVS

Pathology of Coronary Artery Disease

IVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD.

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion

Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans

as a Mechanism of Stent Failure

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection

Integrated Use of IVUS and FFR for LM Stenting

PCI for Left Anterior Descending Artery Ostial Stenosis

FFR and intravascular imaging, which of which?

Percutaneous Intervention of Unprotected Left Main Disease

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

OCT; Comparative Imaging Results with IVUS, VH and Angioscopy

Dr Aniket Puri. OCT guided BVS for LMCA to LAD : Optimising the 'Pot'

September Peter Barlis. Royal Brompton Hospital, London, UK

Usefulness of OCT during coronary intervention

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

Plaque Shift vs. Carina Shift Prevalence and Implication

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience

Radiation Safety Abbott Vascular. All rights reserved.

Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark

Bench test : Is it still useful? Do we need standardization?

ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ

STENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

Assessment of plaque morphology by OCT in patients with ACS

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

LCX. President / Director of Cardiology / New Tokyo Hospital

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital

Bifurcation Stenting: IVUS and OCT Information

Left Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD

DES In-stent Restenosis

Pathology of the Vulnerable Plaque

FESC, FACC, MAHA, MSCAI, MEAPSI, ESH

Insights in Thrombosis and In-Stent Restenosis

Cardiovascular Research Foundation and Columbia University Medical Center, New York.

Important LM bifurcation studies update

1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece

TVA_C02.qxd 8/8/06 10:27 AM Page 19 PART 2. Pathology

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

#1 G.S. Kassab Mathematical modeling of coronary arterial tree

The SYNTAX-LE MANS Study

Unprotected LM intervention

6 th European Bifurcation Club October BUDAPEST. Kissing in simple strategy? Why and how I kiss. Y. Louvard, ICPS, Massy France

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb

Ischemic heart disease

Intravascular Ultrasound

DESolve NX Trial Clinical and Imaging Results

8 th European Bifurcation Club October Barcelona

FFR-guided Jailed Side Branch Intervention

DK Crush,Culotte,SKS,T or TAP. Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi

RESTENOSIS Facing up to the problem

Between Coronary Angiography and Fractional Flow Reserve

Drug Eluting Stents: Bifurcation and Left Main Approach

Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) &

Neointimal coverage of bare-metal and sirolimuseluting stents evaluated with optical coherence tomography

Upgrade of Recommendation

ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική

high SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin Turin / Italy

Complex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique ".

PCI for Ostial Lesion

Jose Mª de la Torre Hernandez, MD, PhD, FESC. Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander. SPAIN

Noninvasive Coronary Imaging: Plaque Imaging by MDCT

High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens

Chapter 43 Noninvasive Coronary Plaque Imaging

Left Main Intervention: Will it become standard of care?

IN-STENT RESTENOSIS. K.Boerlage-van Dijk CarVasZ 2014

IVUS vs FFR Debate: IVUS-Guided PCI

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function

in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC

FFR Fundamentals and Measurements

The Spectrum of Dedicated Stents for Bifurcation Lesions: Current Status and Future Projections. Martin B. Leon, MD

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD

Will Bioresorbable Scaffolds Change How We Think About Left Main PCI?

The Pathology of Neoatherosclerosis in Human Coronary Implants

IVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION

The Latest Experimental Results of Endothelialization with BuMA stent. Renu Virmani, MD CVPath Institute, Inc. Gaithersburg, Maryland, USA

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

Transcription:

Anatomy and Pathology of Left main coronary artery G Nakazawa Tokai Univ. Kanagawa, Japan 1

Anatomy Difinition Left main coronary artery (LMCA): The proximal segment RCA AV LAD LM LCX of the left coronary artery that arises from the left aortic sinus just below the sinotubular junction to its bifurcation into the LAD and LCX LMCA is responsible for supplying approximately 75% of the left ventricular cardiac mass

Anatomy LMCA is generally divided into 3 anatomic regions 1.Ostium (Origin of LMCA from aorta) 2.Middle portion 3.Distal (Bifurcation) i portion Approximately one-third of cases have trification The Average length of LMCA: 10.8±5.2mm (2-23mm) 23mm) The Average angle of terminal brunches: 87±29 (40-165 165 ) Positive correlation: length and angle Reig Jetal al. Clin Anat 2004

Anatomy Specific Features Ostium portion of LMCA is rich in aortic smooth muscle cells and elastic fibers Elastic recoil Bifurcation at the distal portion Flow disturbance (Susceptible to develop the plaque) Procedural Complexity

Anatomic features and the development of atherosclerotic plaque in left main coronary artery: IVUS data Short LMCA (<10mm) (n=44) Long LMCA ( 10mm) (n=43) Ostium 55% 18% Stenosis Location Middle 7% 5% Distal bifurcation 38% 77% Ostial stenosis (n=32) Non-ostial stenosis (n=55) Morphologic Findings Lumen area (mm 2 ) 62 6.2 46 4.6 Plaque burden (%) 62 80 Remodeling index 0.87 1.01 Maehara A, et al. Am J Cardiol. 2001;88:1-4.

Plaque Formation Luminal Narrowing Mean cross sectional luminal narrowing, left main, by age, sudden coronary death 40 35 30 25 20 15 10 5 0 Mean % stenosis < 40 40-49 50-59 60-69 > 70 N=194 yrs yrs yrs yrs yrs Data from CVPath sudden cardiac death registry

Plaque Formation in LMCA Maximal cross sectional luminal narrowing, 194 cases of sudden coronary death 60 50 % narrowing Location of stenosis (>75%) 40 30 20 10 unclassified distal diffuse proximal middle 0 < 25% 25-50% 50% 50-75% >75% N=194

Patients with >75% LM stenosis Proximal LAD and/or LCX involvement 54 Male, sudden death LMCA LM+LCX (33%) LM+LAD (27%) LM only (7%) LM+LAD+LCX (33%) Proximal LAD Proximal CX

Plaque Progression in LMCA PIT Early NC Late NC TCFA

Advanced plaque in LMCA Intraplaque hemorrhage Erosion Plaque rupture Thr Thr NC Thr Hemorrhage

Types of plaque in LMCA in sudden coronary death cases All sudden coronary death cases (n=374) 4% 5% 3% 2% 2% 1% 2% Pathologic intimal thickening (157) Fibroatheroma (82) Fibrocalcific (63) Adaptive intimal thickening (19) 42% Fibrous plaque (13) 17% Healed rupture (12) Acute rupture / fissure (8) Fatty streak (8) Nodularcalcification(6) 22% Thin cap fibroatheroma (5) Erosion (1)

Types of plaque in LMCA in sudden coronary death cases with stenosis 50% Cases with stenosis 50% in sudden coronary death (n=171) 6% 4% Fibroatheroma (53) 3% 3% 3% 2% Fibrocalcific (45) 31% Pathologic intimal thickening (38) Healed rupture (10) Nodular calcification (6) 22% Acute rupture / fissure (5) Thin-cap fibroatheroma (5) 26% Fibrous plaque (5) Fatty streak (3) Erosion (1)

LM Length and Luminal Narrowing, Calcification Sudden coronary death victims with LM luminal narrowing 50% (n=71) LM Prox LAD Prox LCX (%) 90 Luminal area stenosis of LM p=0.032 LM length (mm) <10 (n=20) 80 10, <15 (n=35) LM length LCX 70 15 (n=16) 60 LAD 5 mm 50 LM length (mm) Longer left main had severe luminal narrowing. Calcification (% Area) (%) LM length (mm) 50 p=0.48 p=0.19 p=0.85 <10 (n=20) 40 10, <15 (n=35) 30 15 (n=16) 20 Calcification was the greatest in 10 prox LAD and the least in prox LCX. 0 No significant relationship between LM length and calcification. Left Main Prox LAD Prox LCX

Plaque distribution in bifurcation lesion

Plaque Formation in Bifurcation High shear Low shear Main Vessel proximal A C G B D E F Main Vessel distal (mm) 1.6 1.4 1.2 1 08 0.8 0.6 0.4 02 0.2 0 (mm) 0.6 0.5 0.4 03 0.3 0.2 Plaque thickness * * * * A B C D E F G Necrotic core thickness Flow divider 0.1 * * * Side Branch 0 A B C D E F G Nakazawa G et al. J Am Coll Cardiol. 2010 Apr 20;55(16):1679-87. P<0.05 5, vs. A (*), vs. B ( ), vs. C &D ( )

Plaque Formation LM + LAD severe stenosis

IVUS classification for LMCA bifurcation plaque distribution Oviedo, C. et al. Circ Cardiovasc Interv 2010;3:105-112

Why so susceptive to get diseased? Traub, O. et al. Arterioscler Thromb Vasc Biol 1998;18:677-685

Pathology of Left Main Coronary Artery Stenting Data from CVPath Autopsy Registry

BMS vs DES in LMCA @ Autopsy Patient Characteristics BMS (n=15) DES (n=12) Age 56.0 ± 12.8 73.2 ± 8.8 p=0.001 Gender (f/m) 4/11 3/9 p=0.53 Duration of Survival (days) 189 ± 206 212 ± 324 p=0.98 CABG 5 6 Lesion Characteristics BMS (n=15) DES (n=12) Stent lesion length (mm) 16.2 ± 5.5 29.6 ± 18.0 p= 0.02 Isolated Left Main 2 3 Bifurcation (single vessel) 11 6 Bifurcation (>2 vessels) 1 3 Indication BMS (n=15) DES (n=12) ACS/AMI 2 3 Stable Angina 13 9 Vorpahl M et al. ACC2010

BMS vs DES in LMCA @ Autopsy Pathology BMS> 30 days (n=11) DES >30 days (n=10) 12 8 4 Duration 288 ± 189 340 ± 374 P=0.7019 Stent diameter 3.73±0.67 3.95±0.57 P=0.4437 Vessel ldiameter 573±1 5.73 ±1.00 593±0 5.93±0.93 P=0.6532 Vessel Area 19.47±4.67 20.25±4.61 P=0.7037 Stent Area 76±1 7.6±1.93 851±2 8.51±2.5252 P=0.3725 Plaque Area 11.84±3.85 11.73±3.46 P=0.9476 Lumen Area NeointimalArea %Area StenosisNeointimal Thickness P=0.0804 6 P=0.1525 80 P=0.1825 0.6 P=0.0187 4 60 04 0.4 40 2 20 0.2 BMS DES BMS DES BMS DES BMS DES 0 0 0 0 Vorpahl M et al. ACC2010

Cause of Death at Autopsy with LMCA stenting Cause of Death BMS (n=15) DES (n=12) SRD 6 (40) 7 (58) p=0.26 NSRD 4 (26) 4 (33) NCD 5 (33) 1 (8) SRD: Stent Thrombosis/ Restenosis NSRCD: SCD and patent stent NCD: other Vorpahl M et al. ACC2010

LM CX Early Stent thrombosis 73F, Cypher stent implantation in LMCA Sudden death 2 days after implantation LAD Thr Thr Thr Thr Thr NC

Very Late Stent Thrombosis in LM stent LM LAD (PES2.5 years) LM: PES LAD: PES Diag: PES LCX: PES Lom: BMS LCx Mid Left LftMi Main Lom Diag Thr SCD seven days after discontinuation of Clopidogrel and ASS for lung biopsy. Persistent Inflammation Uncovered dstrutst Occlusive Thrombus Malapposition Fibrin Deposition 4.5 mm

Analysis of Bifurcation Stenting From CVPath Autopsy Cases

DES implantation in Bifurcation Lesion Age (yrs) Male Gender (%) Mean duration (day) >30 days (%) Technique 1 stent 2 stent, T/ V/ Crush Number of stents Restenosis MV (%) SB (%) Thrombosis < 30 days > 30 days DES (n=19) BMS (n=21) p value 61 ± 16 58 ± 17 0.61 15 (79) 13 (62) 0.41 330 [188, 680] 150 [54, 540] 0.14 12 (63) 14 (67) 0.81 10 9 0.38 5/ 2/ 2 9/ 3/ 0 1.9 ± 0.8 1.8 ± 0.8 0.58 1 (6) 7 (33) 0.03 3 (16) 6 (29) 0.7 MV (%) 3 (43) 3 (43) 0.33 SB (%) 3 (43) 4 (57) 073 0.73 MV (%) 9 (75) 5 (36) 0.04 SB (%) 5 (42) 2 (14) 0.35 Timing of thrombus 270 [195, 585] 60 [35, 105] 0.003 Nakazawa G et al. J Am Coll Cardiol. 2010 Apr 20;55(16):1679-87.

Morphometric Analysis Lateral wall 1 or 2 sections Neointimal thickness Fibrin deposition Uncovered struts Flow divider Nakazawa G et al. J Am Coll Cardiol. 2010 Apr 20;55(16):1679-87.

Morphometric Analysis BMS BMS Flow divider Lateral wall p value Neointimal thickness (mm) 042± 0.42 ± 035 0.35 050± 0.50 ± 034 0.34 015 0.15 Struts t with fibrin i (%) 24 ± 30 20 ± 30 031 0.31 Uncovered Strut (%) 17 ± 31 5 ± 10 0.08

Morphometric Analysis DES Flow divider Lateral wall p value Neointimal thickness (mm) 0.08 ± 0.07 0.16 ± 0.09 0.003 Struts t with fibrin i (%) 52 ± 27 36 ± 33 003 0.03 Uncovered Strut (%) 48 ± 33 13 ± 24 <0.0001

Flow disturbance induced by stenting 140 A B 120 C200 100 160 downstream carina upstream Pressure [mm mhg] 80 60 40 20 0 0 0.25 0.5 0.75 1 Time [sec] D E F /min] Flow Rate [ml 120 80 40 0 0 0.25 0.5 0.75 1 Time [sec] downstream (nonstented) Upstream (nonstented) G H I downstream (stented) Upstream (stented) Nakazawa G et al. J Am Coll Cardiol. 2010 Apr 20;55(16):1679-87.

Conclusions LMCA show complex plaque especially when significantly narrowed LAD and/or LCX involvement was common in patients with LMCA stenosis Atherosclerotic plaque was predominantly seen in lateral wall rather than flow divider Because of the plaque complexity, the deployment is important in LMCA stenting Flow disturbance is the primary cause of delayed arterial healing in bifurcation lesion following DES implantation